Tanabe Pharma Corp - Company Profile
Powered by 
All the sales intelligence you need on Tanabe Pharma Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Tanabe Pharma Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Tanabe Pharma Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Tanabe Pharma Corp patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| FI3088517T3 | Grant | Human anti-il-33 neutralizing monoclonal antibody | A61K2039/505; A61K39/3955; A61K39/39591; A61P1/04; A61P1/16; A61P11/00; A61P11/02; A61P11/06; A61P13/12; A61P17/00; A61P17/04; A61P19/02; A61P21/02; A61P27/16; A61P29/00; A61P35/00; A61P37/00; A61P37/02; A61P37/06; A61P37/08; A61P43/00; A61P9/00; C07K16/244; C07K2317/33; C07K2317/34; C07K2317/55; C07K2317/565; C07K2317/76; C07K2317/92; C07K2317/94 | November 30, 2023 |
| US11826352B2 | Grant | Edaravone suspension for oral administration | A61K31/4152; A61K47/32; A61K47/36; A61K9/0053; A61K9/16; A61P21/00 | November 28, 2023 |
| CN117129598A | Application | 3-甲基-1-苯基-2-吡唑啉-5-酮原药的分析方法、该原药及其制造方法和应用 | A61K31/415; A61K31/4152; A61P21/02; C07D231/26; G01N2030/027; G01N2030/042; G01N2030/067; G01N30/06; G01N33/15 | November 28, 2023 |
| EP4275690A3 | Search Report | Vernetzte künstliche nukleinsäure-alna | C12N15/113; C12N2310/315; A61K31/712; A61P43/00; C07H19/06; C07H19/10; C07H19/16; C07H19/20; C07H21/04; Y02P20/55 | November 22, 2023 |
| EP4275689A3 | Search Report | Vernetzte künstliche nukleinsäure-alna | C12N15/113; C12N2310/315; A61K31/712; A61P43/00; C07H19/06; C07H19/10; C07H19/16; C07H19/20; C07H21/04; Y02P20/55 | November 22, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer